Try our Advanced Search for more refined results

W.L. Gore & Associates Inc. et al v. C.R. Bard Inc.

  1. September 20, 2017

    Gore Can't Slip Invalidity Verdict In Stent Patent Row

    A Delaware federal judge on Wednesday denied W.L. Gore & Associates Inc.'s bid to toss a jury's finding that Gore's patent relating to a stent device, which Gore had unsuccessfully alleged was infringed by C.R. Bard Inc., is invalid over prior art.

  2. March 08, 2017

    Bard Stent Grafts Don't Infringe Gore Patents, Jury Finds

    A Delaware federal jury of four men and four women determined Wednesday that an ultrathin stent graft device produced by C.R. Bard Inc. does not infringe a patent held by W.L. Gore & Associates Inc. and that the patent is invalid over prior art.

  3. March 01, 2017

    Long-Awaited IP Trial Between WL Gore, CR Bard Kicks Off

    A long-delayed intellectual property trial over stent graft patents between bitter rivals C.R. Bard Inc. and W.L. Gore & Associates Inc. kicked off in Delaware on Wednesday with Gore suggesting Bard copied its invention and Bard arguing that precise technical information shows that not to be so.

  4. February 08, 2017

    Gore Must Pay Fees After Sanctions Bid Fails In IP Row

    A Delaware federal judge on Wednesday ordered W.L. Gore & Associates to pay a portion of the attorneys' fees that C.R. Bard incurred while responding to the Gore-tex maker's "aggressive" pursuit of sanctions against it and its attorneys in litigation over a stent patent which Gore claims Bard has infringed.

  5. August 11, 2016

    Bard Again Slams Gore's 'Baseless' Sanctions Bid In IP Suit

    C.R. Bard again slammed W.L. Gore & Associates' "baseless" sanctions bid in a stent patent case, telling a Delaware federal judge in a letter Wednesday that there is no way the motion was brought in good faith and that it could have ruined attorneys' careers.

  6. August 08, 2016

    CR Bard Blasts Rival's 'Baseless' Sanctions Bid In IP Suit

    C.R. Bard asked a Delaware federal judge Friday for attorneys' fees it incurred over W.L. Gore & Associates' sanctions bid in a stent patent case, saying the "potentially career-ending allegations" that it was sitting on damaging information to delay a trial were "baseless."

  7. July 29, 2016

    WL Gore Can't Recover Lost Profits In Stent IP Row: Judge

    A Delaware federal judge has ruled that W.L. Gore & Associates Inc. is not entitled to recover lost-profit damages estimated to exceed $100 million in its long-running patent fight over a heart stent against C.R. Bard Inc., according to a ruling unsealed Friday.

  8. July 11, 2016

    Bard Says Jury Shouldn't Decide Triple Damages Bid In IP Suit

    C.R. Bard Inc. has urged a Delaware federal court in a case worth $100 million or more not to allow a jury to decide whether its alleged infringement of a W.L. Gore & Associates Inc. stent patent was willful and therefore worthy of enhanced damages, while Gore argued otherwise.

  9. March 17, 2016

    Gore-Tex Maker Says Antics In Stent IP Row Need Sanctions

    A Delaware federal case over a stent patent with $100 million or more at stake took a side trip into a sanctions hearing Thursday, with W.L. Gore & Associates Inc. accusing medical device maker C.R. Bard Inc. of delaying trial with eleventh-hour claims of damaging information.

  10. December 07, 2015

    Judge Postpones Stent IP Trial Between WL Gore and CR Bard

    A Delaware federal judge reluctantly agreed Monday to postpone the trial between C.R. Bard Inc. and rival medical device maker W.L. Gore & Associates Inc. over stent graft patents at the joint request of the two sides minutes before the jury pool was to be brought into court.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!